U.S. equity markets faced significant selling pressure during afternoon trading on Monday, February 23rd, 2026, as a combination of geopolitical trade uncertainty and renewed anxieties over the long-term impact of artificial intelligence (AI) weighed heavily on investor sentiment. The session was dominated by a sharp pivot toward risk-off behavior following a weekend of escalating trade rhetoric from the White House, effectively erasing the optimism seen late last week.
Major Indexes Retreat in Afternoon Trade
As of mid-afternoon, the major market benchmarks were firmly in the red. The Dow Jones Industrial Average (DOW) plummeted by approximately 814 points, or 1.64%, hovering near the 48,811 level. The S&P 500 (SPX) followed suit, dropping 1.23% to trade around 6,824, while the tech-heavy Nasdaq Composite (IXIC) shed 1.44%, falling to 22,555.
The primary catalyst for the downturn was President Donald Trump’s announcement over the weekend that he would impose a 15% global tariff on imports under Section 122 of the Trade Act of 1974. This move came as a direct retaliation to a Supreme Court ruling on Friday that had struck down previous "reciprocal" tariff measures. The resulting uncertainty regarding global supply chains and potential retaliatory measures from trading partners has sparked a broad liquidation in sectors sensitive to international trade.
Sector Performance and AI Jitters
While trade policy dominated the headlines, the technology sector was further pressured by a "dystopian" research report circulating among institutional investors regarding AI displacement. Software and payment processing companies were particularly hard hit. American Express (AXP) saw its shares tumble nearly 7%, significantly dragging down the Dow, while software giants like Oracle (ORCL) and Palantir Technologies (PLTR) each fell by roughly 4%. Investors are increasingly concerned that AI-powered automation and coding assistants could erode the margins of legacy software providers.
In contrast, the healthcare and biotech sectors provided a pocket of intense activity. Eli Lilly (LLY) rose 4.1% after its primary competitor in the weight-loss market, Novo Nordisk (NVO), reported disappointing trial results. Novo Nordisk shares cratered by nearly 16% after its next-generation obesity drug, CagriSema, failed to demonstrate superiority over Lilly’s Zepbound in a head-to-head study. Meanwhile, Gilead Sciences (GILD) made waves in the biotech space by announcing a $7.8 billion acquisition of Arcellx (ACLX), sending the latter’s stock soaring.
Corporate News and "Magnificent Seven" Performance
The "Magnificent Seven" mega-cap stocks showed mixed but mostly negative performance. Tesla (TSLA) and Amazon (AMZN) led the declines among the group, falling 3.2% and 2.8% respectively, as investors weighed the impact of 15% tariffs on their complex global logistics and manufacturing networks. Microsoft (MSFT) and Alphabet (GOOGL) also traded lower as the market reassessed the massive capital expenditure budgets—estimated at $650 billion collectively for 2026—required to sustain their AI infrastructure.
Bucking the trend, Nvidia (NVDA) managed to stay slightly positive, up 0.6%, as the market anticipates its high-stakes earnings report later this week. Apple (AAPL) also remained relatively resilient, trading near flat as it benefits from its perceived status as a safe-haven within the tech sector.
Upcoming Market Events
The remainder of the week is packed with high-impact events that could determine if the current sell-off stabilizes or accelerates. All eyes are on Nvidia (NVDA), which is scheduled to report quarterly earnings on Wednesday afternoon. Given its role as the primary engine of the AI bull market, its guidance will be critical for broader market direction. Other notable earnings include Home Depot (HD) on Tuesday and Salesforce (CRM) on Wednesday.
On the economic front, the Conference Board will release its Consumer Confidence Index on Tuesday, providing insight into how households are reacting to the latest tariff news and persistent inflation. Furthermore, Federal Reserve Governor Christopher Waller noted in a speech today that the March policy decision remains a "coin flip," placing even greater emphasis on this Friday’s Producer Price Index (PPI) data as a key indicator for the Fed's next move.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.